In this case, Xstrahl 100 was used to treat squamous cell carcinoma on a patient’s nose.
Maui Derm Hawaii 2025 to Feature Xstrahl’s Dual Modality Treatment Solution for Dermatologists
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will feature Radiant Aura at the Maui Derm Hawaii 2025 meeting, January 20-24, 2025. Radiant Aura is a low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.